Most Recent
The former president of the Federation of International Polo, who successfully defeated a defamation suit by a prominent polo benefactor, has failed to recover $1.2 million in legal fees paid to a US law firm.
A judge has ordered the lead applicant in a failed class action against Queensland utilities Stanwell and CS Energy, which was slated to be worth $1 billion, to pay $32.4 million in costs.
The legal watchdog’s latest case against the owners of a Melbourne law firm -- part of countless "collateral" proceedings between the parties -- should be fixed for a final hearing ASAP, a judge has said.
Four proceedings over COVID-19 business interruption losses will be stripped of class action status, with a judge saying most of the common issues were already determined in test cases.
Several insurers have won a dispute with two Melbourne businesses about whether an industrial special risks policy can cover losses suffered during COVID-19 lockdowns, with a judge finding the policy did not respond just because there were recorded cases in Melbourne.
The co-owners of Pacific Werribee shopping centre in Victoria have largely won their bid for insurance documents as they weigh a second case against collapsed construction company, allegedly worth up to $335 million.
Bayer told a jury that clinical trials from the 1990’s to 2014 showed its Essure birth control device was “safe and efficacious”, as the pharmaceutical giant faces trial in a class action by patients who claim they suffered debilitating injuries from the device.
Pharmaceutical giant Bayer cannot write off debilitating chronic pain and bleeding which patients allegedly experienced after being implanted with Essure contraceptives as “common women's symptoms”, a court has heard in the first day of trial in a long-running class action.
A class action against Bayer over its Essure device has won court approval to add new allegations, including that the contraceptive caused sexual dysfunction, with a judge finding the new claims could not have taken the German drug maker by surprise.
Optus has won more time to bring a counterclaim in a $100 million lawsuit by mobile retailer TeleChoice alleging it was misled when the telecommunications giant claimed it would earn the same revenue as in an agreement that was being negotiated with Telstra.